Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Gains from Investment Securities (2022 - 2025)

Zentalis Pharmaceuticals has reported Gains from Investment Securities over the past 4 years, most recently at -$634000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities changed N/A year-over-year to -$634000.0; the TTM value through Sep 2025 reached $634000.0, up 3.76%, while the annual FY2024 figure was $13000.0, 97.84% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$634000.0 at Zentalis Pharmaceuticals, down from $103000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $598000.0 in Q4 2023 and troughed at -$634000.0 in Q4 2025.
  • A 4-year average of $61500.0 and a median of $35000.0 in 2023 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 1425.0% in 2024 and later skyrocketed 1101.89% in 2025.
  • Year by year, Gains from Investment Securities stood at -$68000.0 in 2022, then skyrocketed by 979.41% to $598000.0 in 2023, then tumbled by 108.86% to -$53000.0 in 2024, then plummeted by 1096.23% to -$634000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for ZNTL at -$634000.0 in Q4 2025, $103000.0 in Q3 2025, and $531000.0 in Q2 2025.